Home/Directory/Drug Discovery Services/AbCellera

AbCellera

Vancouver, BC · Canada

Drug Discovery Servicesmid

Specialization: Antibody discovery partnerships

Key Differentiator

Partners with pharma and biotech on antibody discovery under upfront, milestone and royalty deals.

Core Services

Therapeutic antibody discovery; Multispecific and T-cell engager design; Target-to-clinic development; IND-enabling studies; Clinical supply manufacturing

Capabilities

Antibody discovery platformT cell engager and multispecific antibodiesData science and automationIND enabling studiesClinical supply manufacturing

Market Intelligence

Nasdaq-listed (ABCL) and now also a clinical-stage company with its own pipeline. In June 2026 it signed a T-cell engager collaboration with Jazz Pharmaceuticals worth $56 million upfront for two programs; past partners include Lilly, Gilead, Regeneron and Biogen.

Website

www.abcellera.com

Similar Companies

Aragen Life Sciences (US)

Waltham, MA (US); Hyderabad, India (HQ) · Discovery chemistry & biology, DMPK

Growing discovery CRO

BioDuro-Sundia

Irvine, CA (HQ); San Diego, CA; China · Integrated discovery→manufacturing CRDMO

US-HQ CRDMO

Charles River Laboratories

Wilmington, MA (HQ); 150+ locations in 21 countries · GLP toxicology, safety assessment, ADME/DMPK

WORLD'S LARGEST preclinical CRO

Charles River Laboratories (Canada)

Senneville, QC; Sherbrooke, QC; Laval, QC · Drug discovery, safety assessment, DMPK, biologics testing, viral vector manufacturing

World's largest preclinical CRO — major Canadian operations across Quebec

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.